Sort by
Refine Your Search
-
assessments, the research seeks to discover early markers that can facilitate timely diagnosis and inform targeted interventions for infants vulnerable to delayed language development. The successful candidate
-
target specifications of 60 Hz sampling rate and 100 m sampling length. The data for this project will come from a 3-month experiment, scheduled for November 2025 – January 2026, on the two cables
-
associated events that may serve as both therapeutic targets and biomarkers for early onset dementia such as early onset Alzheimer’s disease and frontotemporal dementia. Our research leverages comprehensive
-
, to define novel biomarkers, and to identify novel therapeutical targets. We have pioneered in the integration of genetics with omic data to identify proteomic signatures and develop novel predictive models
-
are dedicated to the development and application of innovative optical technologies aimed at understanding how social behavior is regulated in rodent brain. Our research targets psychiatric disorders such as
-
reveal novel insights into chromatin dysregulation and identify therapeutic targets. We are particularly interested in applicants with a strong background (or keen interest in) chromatin biology
-
dementias. The ultimate goal of the NGI is to understand the biology of these diseases, to define novel biomarkers, and to identify novel therapeutic targets. WashU Medicine is renowned for its research
-
scenarios; building network models in one or more platforms (e.g., loop analysis/qpress; fuzzy cognitive maps/Mental Modeler; Bayesian belief networks; etc.); and interpreting, communicating to broad